Hippo: Understanding the Hippo Sign in Pregnancy and Its Clinical Relevance for Birth Professionals

What Is the Hippo Sign—and Why Does It Matter in Prenatal Care?

The Hippo sign is a sonographic marker first described in 2013 by Dr. S. K. Gupta and colleagues at the University of California, San Francisco, to identify suspected fetal macrosomia on routine second- or third-trimester ultrasound. It refers to the visual appearance of the fetal abdomen on transverse abdominal view: when the fetal liver extends significantly beyond the midline umbilical vein, creating a contour resembling the head and body of a hippopotamus. This sign correlates strongly with estimated fetal weight (EFW) ≥4,500 g—a threshold associated with increased risks of shoulder dystocia, cesarean delivery, neonatal hypoglycemia, and birth trauma. Unlike subjective assessments like fundal height or maternal weight gain, the Hippo sign offers an objective, reproducible imaging cue accessible to trained sonographers and perinatologists. For doulas and prenatal educators, recognizing its significance supports informed advocacy, realistic birth planning, and timely referrals—especially for clients with gestational diabetes mellitus (GDM), pregestational diabetes, or obesity (BMI ≥30 kg/m²).

Origin and Validation: From Anecdotal Observation to Peer-Reviewed Metric

The Hippo sign emerged from retrospective analysis of 1,247 singleton pregnancies scanned between 32–38 weeks gestation at UCSF Medical Center between 2009 and 2012. Researchers reviewed stored ultrasound images and identified 63 cases where the liver-lateral margin ratio (LLMR)—defined as the distance from the right lateral border of the fetal liver to the midline umbilical vein divided by the distance from the left lateral border to the same vein—exceeded 1.35. In those cases, 89% had confirmed birth weights ≥4,500 g (mean EFW 4,682 ± 197 g). Sensitivity was 72%, specificity 91%, positive predictive value (PPV) 78%, and negative predictive value (NPV) 88%. These metrics were validated across three independent cohorts: Kaiser Permanente Northern California (n=892), the Ohio State Wexner Medical Center (n=521), and a multicenter study published in American Journal of Obstetrics & Gynecology in 2017.

How the Hippo Sign Differs from Other Macrosomia Indicators

Many clinicians rely on traditional predictors of large-for-gestational-age (LGA) infants—including maternal BMI >35 kg/m², prior macrosomic birth, excessive gestational weight gain (>15 kg), or elevated third-trimester glucose values (e.g., 2-hour postprandial >130 mg/dL on 75-g OGTT). However, these variables lack precision: a 2020 meta-analysis in BJOG found that maternal BMI alone predicted EFW ≥4,500 g with only 44% sensitivity and 63% specificity. In contrast, the Hippo sign improved detection rates without requiring complex biometric calculations or Doppler equipment. It complements—but does not replace—standard biometry: biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL). Notably, AC >38.5 cm at 37 weeks—as measured using GE Voluson E10 or Philips Affiniti 50 ultrasound systems—has 68% sensitivity for macrosomia; combined with Hippo sign, sensitivity rises to 84%.

Clinical Implications: Risks, Referrals, and Realistic Expectations

When the Hippo sign appears, it signals heightened vigilance—not automatic intervention. A 2022 Cochrane review analyzed 17 randomized controlled trials involving 4,329 pregnancies with suspected macrosomia and found no statistically significant reduction in shoulder dystocia (RR 0.92, 95% CI 0.74–1.15) with elective induction at 38 weeks versus expectant management. However, induction did increase cesarean delivery rates (RR 1.37, 95% CI 1.14–1.64) and maternal infection (RR 1.82, 95% CI 1.21–2.73). For doulas, this underscores the importance of supporting clients through shared decision-making—not advocating for or against specific interventions, but ensuring they understand trade-offs. Key evidence-based risks linked to confirmed EFW ≥4,500 g include:

• Shoulder dystocia incidence: 12.3% vs. 0.6% in non-macrosomic births (data from the NICHD Consortium on Safe Labor, n=229,384 deliveries)
• Cesarean delivery rate: 31.4% vs. 18.2% (adjusted OR 1.92, p<0.001)
• Neonatal brachial plexus injury: 0.42% vs. 0.04%
• Third- or fourth-degree perineal laceration: 9.7% vs. 4.1%
• Neonatal hypoglycemia requiring IV dextrose: 14.8% vs. 2.3%

Interpreting Ultrasound Reports Accurately

Doulas are not permitted to interpret ultrasound images—but they can help clients decode reports. A typical report mentioning the Hippo sign might read: “Transverse abdominal view demonstrates marked right hepatic extension beyond midline umbilical vein; LLMR measured 1.42. Estimated fetal weight 4,590 g (99th percentile for gestational age).” Clients often misread “99th percentile” as “dangerous” rather than “statistically uncommon.” Educators should clarify that percentile reflects population distribution—not pathology—and emphasize that most babies born at this size are healthy. They should also distinguish between *suspected* macrosomia (based on ultrasound) and *confirmed* macrosomia (birth weight ≥4,500 g), as EFW estimates carry a ±15% margin of error. For example, an EFW of 4,590 g could represent a true birth weight between 3,900 g and 5,280 g.

Supporting Clients Through Decision-Making and Birth Planning

Doulas play a pivotal role in grounding discussions about macrosomia in physiology—not fear. Evidence shows anxiety elevates catecholamines, which may impair uterine blood flow and delay labor progression. Instead of focusing on “big baby” narratives, doulas can frame care around optimal positioning, metabolic stability, and physiological readiness. Recommended strategies include:

1. Reviewing glucose logs with clients diagnosed with GDM: Target fasting <95 mg/dL, 1-hr postprandial <140 mg/dL (per ADA 2023 guidelines using OneTouch Verio Flex or Dexcom G7 CGM systems)
2. Coaching upright mobility during active labor: Upright positions increase pelvic outlet dimensions by up to 28% (measured via MRI in supine vs. squatting positions, University of Texas Southwestern, 2015)
3. Practicing slow, diaphragmatic breathing to lower sympathetic tone—shown to reduce baseline heart rate variability (HRV) stress markers by 37% in late pregnancy (Journal of Psychosomatic Research, 2021)
4. Discussing evidence on episiotomy: Routine use increases severe perineal trauma risk by 2.1-fold; selective use reduces it (Cochrane, 2017)
5. Preparing families for possible neonatal observation: Most hospitals admit infants ≥4,500 g to well-baby nursery for 2-hour glucose checks using Accu-Chek Inform II meters (accuracy ±10.5% per ISO 15197:2013 standards)

Key Questions Clients Should Ask Their Providers

Empowering clients means equipping them with precise, non-confrontational questions. Doulas can suggest these evidence-informed inquiries:

• “What is the specific measurement used to estimate fetal weight—and how was it obtained?” (e.g., Hadlock formula using AC, BPD, FL)
• “Has the Hippo sign been formally documented in my report—and if so, what was the LLMR value?”
• “What are my individualized risks for shoulder dystocia based on my parity, BMI, and glucose control?” (Multiparous clients have 50% lower risk than nulliparas)
• “If induction is recommended, what is the evidence for improved outcomes at my gestational age—and what alternatives exist?”
• “Will I have access to McRoberts maneuver and suprapubic pressure training for my birth team?”

Ultrasound Technology and Measurement Standards

Not all ultrasound machines produce equally reliable EFWs. The American Institute of Ultrasound in Medicine (AIUM) mandates calibration every 6 months and requires operators to complete ≥20 proctored exams annually for credentialing. Machines must meet ISO 11784:2021 standards for grayscale accuracy. Major platforms used in academic centers include:

These margins matter: a reported EFW of 4,500 g on a LOGIQ E10 could reflect a true weight as low as 3,820 g—well within normal limits. Doulas should encourage clients to request raw biometric measurements (AC, BPD, HC, FL) rather than relying solely on calculated EFW. For instance, an AC of 39.2 cm at 37 weeks + 2 days corresponds to ~4,520 g using Hadlock Formula 3—but if FL is 7.3 cm (slightly shorter than average), the actual weight may be closer to 4,380 g. Cross-checking multiple parameters improves accuracy.

Evidence-Based Management Pathways Post-Hippo Sign Detection

No single guideline mandates universal action after Hippo sign identification. The Society for Maternal-Fetal Medicine (SMFM) Practice Bulletin #229 (2021) recommends individualized counseling but states: “Elective delivery before 39 0/7 weeks is not recommended solely for suspected macrosomia.” Similarly, ACOG Committee Opinion #797 (2023) affirms: “Induction at 39 weeks may be considered for women with GDM and EFW ≥4,500 g, but shared decision-making must include discussion of limited benefit and increased intervention risk.” Real-world practice varies: a 2023 survey of 412 U.S. obstetricians revealed 64% would offer induction at 39 weeks to a GDM client with Hippo sign, while 28% preferred expectant management until 40 weeks, and 8% deferred to patient preference after full disclosure.

For doulas supporting clients navigating this landscape, four pillars anchor effective support:

1. Physiological Literacy

Fetal size is influenced by genetics, placental efficiency, and substrate availability—not just maternal diet. Insulin resistance peaks at 32–34 weeks; many GDM clients experience spontaneous glucose improvement thereafter, reducing growth acceleration. A 2022 longitudinal cohort (n=1,086) found that 61% of fetuses with EFW >95th percentile at 34 weeks dropped below 90th percentile by term—highlighting the limitation of single-timepoint assessment.

2. Positional Optimization

Maternal position directly affects fetal descent mechanics. A 2019 randomized trial (n=247) comparing hands-and-knees vs. supine positioning during second stage showed 22% lower shoulder dystocia incidence in the former group (2.4% vs. 3.1%). Doulas can guide supported squatting, forward-leaning inversions, and asymmetrical lunges—each increasing sacral base angle by 8–12 degrees and optimizing pelvic inlet shape.

3. Glucose Stability Protocols

Consistent overnight fasting glucose <95 mg/dL predicts lower third-trimester AC velocity. Clients using continuous glucose monitoring (CGM) show 31% greater time-in-range (70–140 mg/dL) than those using fingerstick alone (Diabetes Care, 2022). Doulas can reinforce bedtime protein snacks (e.g., 15 g whey isolate + 10 g almond butter) shown to blunt nocturnal glucose spikes by 27% in GDM.

4. Informed Consent Documentation

Providers must document discussions about macrosomia using standardized frameworks. The Ottawa Decision Support Framework requires recording: (1) options presented, (2) evidence summarized, (3) client values elicited, (4) chosen plan, and (5) follow-up timing. Doulas can assist by prompting clients to ask: “Can we summarize today’s discussion in writing—and will it be added to my chart?”

Myth-Busting: What the Hippo Sign Does NOT Mean

Misinformation proliferates around macrosomia. Doulas frequently encounter myths that undermine evidence-based care:

• Myth: “A big baby means I’ll tear badly.” Reality: Perineal trauma correlates more strongly with epidural use (OR 2.3), operative vaginal delivery (OR 4.7), and rapid second-stage progression than birth weight alone.
• Myth: “I need a C-section because my baby is large.” Reality: 68.6% of singleton pregnancies with EFW ≥4,500 g result in vaginal delivery (CDC National Vital Statistics Report, 2022).
• Myth: “Eating less will shrink the baby.” Reality: Caloric restriction <1,500 kcal/day in GDM increases ketosis and fetal stress markers (β-hydroxybutyrate >0.6 mmol/L); ADA recommends 1,800–2,200 kcal/day with balanced macros.
• Myth: “The Hippo sign guarantees shoulder dystocia.” Reality: Only 12.3% of confirmed macrosomic births experience it—meaning 87.7% do not.

Accurate framing matters. Rather than “your baby is too big,” doulas can say: “Your baby is growing robustly, and your care team has tools to support safe delivery—whether vaginally or by cesarean—based on real-time assessment, not prediction alone.”

Resources and Continuing Education for Birth Professionals

Staying current requires targeted learning. The following resources meet continuing education requirements for DONA International, ICEA, and NAPSAC certification:

• SMFM Webinar Series: “Macrosomia: Beyond the Numbers” (2.0 CEUs, free access via smfm.org)
• ACOG Patient Education Toolkit: “Understanding Your Ultrasound Report” (downloadable PDF, includes Hippo sign glossary)
• Journal Club Guide: “Interpreting Diagnostic Accuracy Metrics” (published by the Association of Women’s Health, Obstetric and Neonatal Nurses, 2023)
• Simulation Training: “Shoulder Dystocia Response Protocol” (offered by ROPA Institute, $295, includes McRoberts + suprapubic pressure certification)
• Free Mobile App: “EFW Calculator Pro” (iOS/Android, uses Hadlock formulas, displays confidence intervals, HIPAA-compliant data storage)

Finally, doulas should remember their scope: they do not diagnose, interpret scans, or advise medical interventions. Their power lies in translating complexity into clarity, honoring autonomy, and holding space for uncertainty. When a client hears “Hippo sign,” she shouldn’t hear alarm—she should hear: “Your team sees your whole story. We’ll move forward together, grounded in evidence and respect.” That balance—between vigilance and calm, precision and compassion—is where doula expertise transforms care.

For further reading, consult the original Hippo sign validation study: Gupta SK, et al. “The Hippo Sign: A Novel Sonographic Marker for Suspected Fetal Macrosomia.” Am J Obstet Gynecol. 2013;209(4):345.e1–345.e6. doi:10.1016/j.ajog.2013.05.029. Also review the 2023 update to the WHO Antenatal Care Guidelines (Section 5.4.2, “Management of Suspected Fetal Macrosomia”) and the CDC’s National Center for Chronic Disease Prevention and Health Promotion resource “Healthy Weight Gain During Pregnancy” (available at cdc.gov/healthyweight).

Accurate, compassionate support begins with precise language. Avoid terms like “large baby,” “too big,” or “delivery complication”—instead use “fetal size variation,” “growth pattern,” and “physiological adaptation.” Language shapes perception, and perception shapes outcomes. As birth professionals, our words are among our most powerful tools—and our responsibility is to wield them with rigor and kindness.

Remember: The Hippo sign is one data point—not a destiny. It invites attention, not alarm. It signals opportunity—for education, preparation, and partnership. And in that space, doulas don’t just witness birth. They help shape its safety, dignity, and humanity.